Subsequent infectious doses increase viral load and COVID-19 disease severity
Is it true that subsequent infectious doses increase viral load and COVID-19 disease severity?
Partly. The relationship between initial viral dose, subsequent viral load, and COVID-19 severity remains contested. While several clinical and modeling studies link higher viral loads and larger inocula to worse disease outcomes, other retrospective and cohort findings report no significant correlation between viral burden and clinical severity.
Verdict: CONTESTED · 5 sources for, 2 against · Last checked
The claim addresses two related ideas: that subsequent infectious doses increase viral load, and that viral load / inoculum size increases COVID-19 disease severity. The provided literature features direct support for a correlation between viral load/inoculum and severity (papers 0, 2, 6, 7, 8), alongside conflicting studies finding no such association (papers 3, 9). Because there is direct disagreement among the retrieved studies regarding whether viral load reliably predicts or drives disease severity, the correct verdict is CONTESTED.
The evidence we hold leans leans supported
How this was weighed
official record 3x · fact-check 2x · hedged 1x · crowd & reference 1x
- SARS-CoV-2 viral load is associated with increased disease s · peer-reviewed · supports · weight 2 · 2020
- Importance of non-pharmaceutical interventions in lowering t · peer-reviewed · supports · weight 1.6 · 2021
- SARS-CoV-2 viral load as a predictor for disease severity in · peer-reviewed · supports · weight 1.3 · 2021
- Initial Inoculum and the Severity of COVID-19: A Mathematica · peer-reviewed · supports · weight 1.3 · 2020
- SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Mod · peer-reviewed · supports · weight 1.3 · 2023
- COVID-19 viral load not associated with disease severity: fi · peer-reviewed · refutes · weight 1.6 · 2021
- Lowering SARS-CoV-2 viral load might affect transmission but · peer-reviewed · refutes · weight 1.3 · 2021
Get citation
Fajnzylber, J., Regan, J., Coxen, K., Corry, H., Wong, C., Rosenthal, A., Worrall, D. P., Giguel, F. F., Piechocka-Trocha, A., Atyeo, C., Fischinger, S., Chan, A., Flaherty, K., Hall, K., Dougan, M., Ryan, E., Gillespie, E., Chishti, R., Li, Y., Jilg, N., Hanidziar, D., Baron, R., Baden, L., Tsibris, A. M., Armstrong, K., Kuritzkes, D., Alter, G., Walker, B., Yu, X., Li, J. Z., Bartsch, B. A. (. P. D. A. J. M. Y. A. A. A. B. B. B., Abayneh, B. A., Allen, P., Antille, D., Balazs, A., Bals, J., Barbash, M., Bartsch, Y., Boucau, J., Boyce, S., Braley, J., Branch, K., Broderick, K. T., Carney, J., Chevalier, J. M., Choudhary, M., Chowdhury, N., Cordwell, T., Daley, G., Davidson, S. P., Desjardins, M., Donahue, L., Drew, D. A., Einkauf, K., Elizabeth, S., Elliman, A., Etemad, B., Fallon, J., Fedirko, L., Finn, K. K., Flannery, J., Forde, P. J., Garcia-Broncano, P., Gettings, E., Golan, D., Goodman, K., Griffin, A., Grimmel, S., Grinke, K. A., Hartana, C., Healy, M. D., Heller, H., Henault, D., Holland, G., Jiang, C., Jordan, H., Kaplonek, P., Karlson, E., Karpell, M., Kayitesi, C., Lam, E. C., LaValle, V., Lefteri, K., Lian, X., Lichterfeld, M., Lingwood, D., Liu, H., Liu, J., Lopez, K. A., Lu, Y., Luthern, S., Ly, N. L., MacGowan, M., Magispoc, K., Marchewka, J., Martino, B., McNamara, R., Michell, A. R., Millstrom, I., Miranda, N., Nambu, C., Nelson, S., Noone, M., Novack, L., O’Callaghan, C., Ommerborn, C., Osborn, M., Pacheco, L. C., Phan, N., Pillai, S., Porto, F. A., Rassadkina, Y., Reissis, A., Ruzicka, F., Seiger, K. W., Selleck, K., Sessa, L., Sharpe, A., Sharr, C., Shin, S. A., Singh, N. K., Slaughenhaupt, S., Sheppard, K., Sun, W., Sun, X., Suschana, E., Talabi, O., Ticheli, H., Weiss, S., Wilson, V., & Zhu, A. (2020). SARS-CoV-2 viral load is associated with increased disease severity and mortality. doi.org. https://doi.org/10.1038/s41467-020-19057-5
Get citation
Abdulrahman, A., Mallah, S. I., & Alqahtani, M. (2021). COVID-19 viral load not associated with disease severity: findings from a retrospective cohort study. doi.org. https://doi.org/10.1186/s12879-021-06376-1
See more details
Get citation
Spinelli, M. A., Glidden, D., Gennatas, E., Bielecki, M., Beyrer, C., Rutherford, G., Chambers, H., Goosby, E., & Gandhi, M. (2021). Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity. doi.org. https://doi.org/10.1016/S1473-3099(20)30982-8
Get citation
Knudtzen, F. C., Jensen, T. G., Lindvig, S. O., Rasmussen, L. D., Madsen, L., Hoegh, S. V., Bek-Thomsen, M., Laursen, C., Nielsen, S. L., & Johansen, I. (2021). SARS-CoV-2 viral load as a predictor for disease severity in outpatients and hospitalised patients with COVID-19: A prospective cohort study. doi.org. https://doi.org/10.1371/journal.pone.0258421
Get citation
Fain, B. & Dobrovolny, H. (2020). Initial Inoculum and the Severity of COVID-19: A Mathematical Modeling Study of the Dose-Response of SARS-CoV-2 Infections. doi.org. https://doi.org/10.3390/epidemiologia1010003
Get citation
Handley, A., Ryan, K., Davies, E. R., Bewley, K., Carnell, O. T., Challis, A., Coombes, N., Fotheringham, S., Gooch, K., Charlton, M., Harris, D., Kennard, C., Ngabo, D., Weldon, T. M., Salguero, F., Funnell, S., & Hall, Y. (2023). SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Model of Infection Is Related to the Volume of Intranasal Inoculum. doi.org. https://doi.org/10.3390/v15030748
Get citation
Trunfio, M., Calcagno, A., Bonora, S., & Perri, G. d. (2021). Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases. doi.org. https://doi.org/10.1016/S1473-3099(21)00205-X
- Is it true that the initial viral load of COVID-19 affects disease severity? SUPPORTED
- Is it true that specific risk factors consistently determine disease severity in COVID-19? SUPPORTED
- Is it true that mosquitoes transmit infectious diseases to humans? SUPPORTED
- Is it true that deforestation increases the risk of emerging infectious diseases? CONTESTED PARTIAL
- Is it true that antibodies are not used as treatments for infectious diseases? REFUTED
Receipt History
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work